U.S. Department of Defense Awards ForeScout Enterprise-wide IoT Security Agreement
ForeScout joins Pentagon's ESI program to accelerate military's use of commercial software, helping defense agencies centralize and expand ForeScout deployments
SAN JOSE, Calif., Jan. 11, 2018 (GLOBE NEWSWIRE) -- ForeScout Technologies, Inc., a leading Internet of Things (IoT) security company, today announced that the U.S. Department of Defense (DoD) awarded the company and its federal partners an enterprise-wide blanket purchase (BPA) agreement through the U.S. military's Enterprise Software Initiative (ESI) program. ForeScout's partners facilitating ESI purchases are Alamo City Engineering Services, Inc., Carahsoft Technology Inc., DLT Solutions, immixTechnology, Inc. and Patriot Technologies, Inc. Eligible agencies can view full award details here: http://www.esi.mil/contentview.aspx?id=926.
This agreement provides the most current commercially available ForeScout products, maintenance and support for DoD, intelligence community and Coast Guard activities worldwide. The products offered through the BPA include ForeScout CounterAct
® agentless security solutions, Enterprise Manager and Extended Modules for third-party orchestration, as well as ControlFabric
Architecture, ForeScout training and ActiveCare
® support services.
"The Department of Defense has been an IoT pioneer since the military's earliest networked sensors, weapons and vehicle platforms and today runs some of the largest connected device portfolios in the world," said Niels Jensen, senior vice president of U.S. Public Sector Sales at ForeScout. "ForeScout's selection for the ESI program underscores the Pentagon's strategic focus on IoT security and helps validate the proven advantages ForeScout professionals are delivering for DoD customers in demanding environments."
ForeScout helps both defense and civilian federal agencies discover, classify and manage diverse devices and applications arriving on networks via the IoT's explosive growth. This new enterprise-wide ESI award expands on ForeScout's ongoing work to help defense organizations implement the DoD's "Comply-to-Connect" (C2C) framework, which is responsible for protecting IoT devices and traditional IT systems from evolving security threats. Military agencies and their contractor partners already use CounterACT to maintain visibility and control over connected devices under C2C, keeping IT systems in compliance with DoD Chief Information Officer (CIO) security policies and U.S. Cyber Command operational orders.
ForeScout CounterACT offers a powerful, flexible platform that gives comprehensive protection to defense organizations' connected assets - from laptops and ruggedized devices in the field, to IoT gear and networked Industrial Internet of Things (IIoT) and operational technology (OT) control systems across bases and shared facilities. CounterACT's agentless technology discovers, classifies and assesses devices. After discovering a device, CounterACT uses a combination of passive and active methods to classify the device according to its type and ownership, then assesses the device's security posture and allows an organization to set policies establishing authorized behaviors.
In DoD deployments, CounterACT seamlessly meets rigorous C2C requirements, including:
- Network-based discovery and classification of devices
- Redundant manageability and control of devices
- Orchestration with other mandated security technologies, such as the DoD's Host Based Security System (HBSS) and Assured Compliance Assessment Solution (ACAS) - confirming these third-party tools are configured and functioning properly
- Continuous monitoring of connected devices
DoD ESI is an official DoD initiative sponsored by the DoD Chief Information Officer (CIO) to lead in the establishment and management of enterprise commercial, off-the-shelf (COTS) IT agreements, assets and policies. DoD ESI lowers the total cost of ownership across the DoD, Coast Guard and Intelligence Communities for commercial software, IT hardware and services.
- ForeScout's enterprise award details: ESI Web site
- Follow ForeScout online: Facebook | Twitter | LinkedIn | Blog
- ForeScout corporate brochure: https://forescout.com/forescout-company-brochure-pr/
ForeScout Technologies, Inc. helps make the invisible visible. Our company provides Global 2000 enterprises and government agencies with agentless visibility and control of traditional and IoT devices the instant they connect to the network. Our technology integrates with disparate security tools to help organizations accelerate incident response, break down silos, automate workflows and optimize existing investments. Learn more at www.forescout.com.
Media Relations Contact:
ForeScout Technologies, Inc.
Investor Relations Contact:
ForeScout Technologies, Inc.
© 2018. ForeScout Technologies, Inc. is a Delaware corporation. ForeScout, the ForeScout logo, ActiveResponse, ControlFabric, CounterACT, CounterACT Edge and SecureConnector are trademarks or registered trademarks of ForeScout. Other names mentioned may be trademarks of their respective owners.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ForeScout via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
CORRECTION - Elite Petro & Gas broadens financial services and signs a deal with Tabarak Investment Capital Limited18.10.2018 23:35 | Pressemelding
DUBAI, United Arab Emirates, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Today the President of Elite Petro & Gas, Mr. George Matharu and the President of Tabarak Investment Capital Limited (Investment Bank), Dr. Mohamed Ahmadi announced a deal in which the two companies will use their combined resources to execute physical commodity trades, and provide banking and finance facilities for oil and gas transactions. The alliance between the two entities will also allow compliance related activities to be carried out from two major international hubs of London and Dubai. This increases the international presence of both companies. Additionally, Elite Petro & Gas (“EPG”) has recently formed relationships with the owners of a number of high profile European, South American and Chinese projects, which EPG and Tabarak can work on together. Tabarak Investment Capital Limited is a regulated investment bank by Dubai Financial Services Authority and incorporated in the Dubai International Financial Centre.
Partnership Between Zaiput Flow Technologies and ThalesNano Set to Improve Process Intensification18.10.2018 15:21 | Pressemelding
BUDAPEST, Hungary and WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zaiput Flow Technologies, a global leader in separation, and ThalesNano, the world leader in bench-top flow chemistry reactors, recently signed a distribution agreement and entered into a technology partnership that exploits the benefits of their combined technologies. Under the distribution Zaiput liquid-liquid phase separators and back pressure regulators are available via ThalesNano in Europe and a number of other countries on a non-exclusive basis, either separately or as part of a bundled offering with ThalesNano’s own microflow reactors. Within the framework of the technology partnership the companies will collaborate to promote adoption of the combined use of their technologies. “We are very excited to work with ThalesNano to offer better-integrated flow chemistry systems to our customers and streamline the work of both novice and experienced users in the flow chemistry space,” said Zaiput CEO, Dr. Andrea Ad
Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer18.10.2018 14:03 | Pressemelding
NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer. As a result, former Chief Medical Officer Juan Ruiz, M.D., Ph.D. will assume the role of Head of European Medical Affairs. The Company also announced the appointment of Neena Patil, J.D. as General Counsel and Corporate Secretary. Both Dr. Siffert and Ms. Patil report to Chief Executive Officer, Carsten Thiel, Ph.D. “I am very pleased to welcome João and Neena to Abeona, and confident in their abilities to make important contributions to the future growth of our company,” said Dr. Thiel. “João has an ideal blend of clinical, scientific, and regulatory experience to reference as we look to advance our clinical and pre-clinical can
Meltwater and Dow Jones Announce Global Partnership to Provide Premium Content18.10.2018 14:00 | Pressemelding
SAN FRANCISCO and NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Meltwater, a global leader in media intelligence, today announces the launch of a partnership with Dow Jones, a global provider of news and business information, to provide premium licensed content from Dow Jones Factiva into the Meltwater Media Intelligence platform. This partnership will give Meltwater’s PR and communications clients the ability to monitor and analyze premium licensed content across thousands of Factiva news sources globally, including: The Wall Street Journal, America’s largest newspaper by paid circulation; Barron’s; MarketWatch; and Dow Jones Newswires. “Meltwater provides our clients with the most comprehensive content network globally, across news, social media and broadcast media. This new Dow Jones partnership will further strengthen our leadership position and allow our clients to access licensed content from some of the most highly-respected news outlets in the world. We’re excited about this part
Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting18.10.2018 13:30 | Pressemelding
EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster session. Data to be presented across the Alzheimer’s disease clinical development portfolio, including aducanumab, BAN2401 and elenbecestat CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) announced it will present data from its Alzheimer’s disease (AD) clinical development portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting in Barcelona, Spain (October 24-27). The data being presented are part of Biogen’s ongoing research programs targeting possible causes of the disease through multiple modalities. “We are excited to engage with the scientific community at CTAD, to share learnings from our Alzheimer’s disease clinical research and to learn from the work of our colleagues around the world. We have hopes that our
SEMAFO Provides Notice of Third Quarter 2018 Results Release and Conference Call 18.10.2018 13:30 | Pressemelding
MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- SEMAFO (TSX, OMX: SMF) invites you to participate in a conference call on November 7, 2018 at 10:00 AM EST with senior management during which they will review the Corporation's third quarter 2018 financial and operational results. SEMAFO's financial statements and management's discussion and analysis for the third quarter 2018 will be released on November 6 after market hours and will be available in the “Investor Relations” section of the Corporation's website at www.semafo.com , and on the Canadian Securities Administrators' website at www.sedar.com . A live audio webcast of the conference call will be accessible for a period of 30 days through SEMAFO’s website at www.semafo.com . Tel. local & overseas: +1 (647) 788 4922 Tel. North America: 1 (877) 223 4471 Webcast: www.semafo.com Replay overseas: +1 (416) 621 4642 Replay N. America: 1 (800) 585 8367 Replay pass code: 2823689 Expiration: December 7, 2018 About SEMAFO SEMAFO is a Canadian-b
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom